§329-16  Schedule II.  (a)  Thecontrolled substances listed in this section are included in schedule II.

(b)  Any of the following substances, exceptthose narcotic drugs listed in other schedules, whether produced directly orindirectly by extraction from substances of vegetable origin, or independentlyby means of chemical synthesis, or by combination of extraction and chemicalsynthesis:

(1)  Opium and opiate, and any salt, compound,derivative, or preparation of opium or opiate, including the following:

(A)  Raw opium;

(B)  Opium extracts;

(C)  Opium fluid;

(D)  Powdered opium;

(E)  Granulated opium;

(F)  Codeine;

(G)  Ethylmorphine;

(H)  Etorphine hydrochloride;

(I)  Hydrocodone;

(J)  Hydromorphone;

(K)  Metopon;

(L)  Morphine;

(M)  Oxycodone;

(N)  Oxymorphone;

(O)  Thebaine;

(P)  Dihydroetorphine;

(Q)  Oripavine; and

(R)  Tincture of opium;

(2)  Any salt, compound, isomer, derivative, orpreparation thereof which is chemically equivalent or identical with any of thesubstances referred to in paragraph (1), but not including the isoquinolinealkaloids of opium;

(3)  Opium poppy and poppy straw;

(4)  Coca leaves and any salt, compound, derivative,or preparation of coca leaves, and any salt, compound, derivative, orpreparation thereof which is chemically equivalent or identical with any ofthese substances, but not including decocanized coca leaves or extractionswhich do not contain cocaine or ecgonine; cocaine or any salt or isomerthereof; and

(5)  Concentrate of poppy straw (the crude extract ofpoppy straw in either liquid, solid, or powder form that contains thephenanthrene alkaloids of the opium poppy).

(c)  Any of the following opiates, includingtheir isomers, esters, ethers, salts, and salts of isomers, whenever theexistence of these isomers, esters, ethers, and salts is possible within thespecific chemical designation:

(1)  Alfentanil;

(2)  Alphaprodine;

(3)  Anileridine;

(4)  Bezitramide;

(5)  Bulk Dextropropoxyphene (nondosage form);

(6)  Carfentanil;

(7)  Dihydrocodeine;

(8)  Diphenoxylate;

(9)  Fentanyl;

(10)  Isomethadone;

(11)  Levo-alphacetylmethadol (LAAM);

(12)  Levomethorphan;

(13)  Levorphanol;

(14)  Metazocine;

(15)  Methadone;

(16)  Methadone-Intermediate,4-cyano-2-dimethylamino-4, 4-diphenyl butane;

(17)  Moramide-Intermediate, 2-methyl-3-morpholino-1,1-diphenyl-propane-carboxylic acid;

(18)  Pethidine (Meperidine);

(19)  Pethidine-Intermediate-A,4-cyano-1-methyl-4-phenylpiperidine;

(20)  Pethidine-Intermediate-B,ethyl-4-phenylpiperidine-4-carboxylate;

(21)  Pethidine-Intermediate-C,1-methyl-4-phenylpiperidine-4-carboxylic acid;

(22)  Phenazocine;

(23)  Piminodine;

(24)  Racemethorphan;

(25)  Racemorphan;

(26)  Remifentanil; and

(27)  Sufentanil.

(d)  Depressants.  Unless specifically exceptedor unless listed in another schedule, any material, compound, mixture, or preparationwhich contains any quantity of the following substances having a depressanteffect on the central nervous system, including their isomers, esters, ethers,salts, and salts of isomers, esters, and ethers, unless specifically excepted,whenever the existence of these isomers, esters, ethers, and salts is possiblewithin the specific chemical designation:

(1)  Amobarbital;

(2)  Glutethimide;

(3)  Pentobarbital;

(4)  Phencyclidine;

(5)  Secobarbital.

(e)  Stimulants. Any material, compound, mixture, or preparation which contains any quantity ofthe following substances having a danger or probable danger associated with a stimulanteffect on the central nervous system:

(1)  Amphetamine, its salts, optical isomers, andsalts of its optical isomers;

(2)  Any substance which contains any quantity ofmethamphetamine, including its salts, isomers, and salts of isomers;

(3)  Phenmetrazine and its salts;

(4)  Methylphenidate; and

(5)  Lisdexamfetamine, its salts, isomers, and saltsof its isomers.

(f)  Immediate precursor.  Unless listed inanother schedule, any material, compound, mixture, or preparation whichcontains any quantity of the following substances:

(1)  Immediate precursor to amphetamine andmethamphetamine:

(A)  Phenylacetone, phenyl-2-propanone(P2P),benzyl methyl ketone, methyl benzyl ketone or

(2)  Immediate precursors to phencyclidine (PCP):

(A)  1-phenylcyclohexylamine; and

(B)  1-piperidinocyclohexanecarbonitrile(PCC).

(g)  Hallucinogenic substances, unless listedin another schedule, shall include:

(1)  Nabilone. [L 1972, c 10, pt of §1 and am c 114,§2(2); am L 1974, c 217, §2; am L 1975, c 26, §1; am L 1978, c 68, §3; am L1979, c 194, §2; am L 1981, c 125, §§1, 2; am L 1984, c 166, §2; am L 1985, c150, §2; am L 1987, c 203, §1; am L 1988, c 59, §2; am L 1990, c 138, §4; am L1991, c 159, §7; am L 1995, c 122, §2; am L 1997, c 356, §2; am L 2000, c 98,§§2, 3; am L 2001, c 203, §3; am L 2002, c 165, §1; am L 2003, c 151, §3; am L2008, c 119, §4; am L 2009, c 117, §§1,2]

 

Case Notes

 

  Method used to prove that capsules of methaqualonehydrochloride contained methaqualone accepted as evidence.  1 H. App. 31, 613P.2d 919.